Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SBI Group

Investor type Investment Bank


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 93
Average round size
The average size of a deal this fund participated in
Portfolio companies 74
Rounds per year 4.04
Lead investments 28
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 14
Key employees 1

Areas of investment

  • Financial Services
  • FinTech
  • Finance
  • Information Technology
  • Software

The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Tokyo.

The overall number of key employees were 1.

Opposing the other organizations, this SBI Group works on 24 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. When the investment is from SBI Group the average startup value is more than 1 billion dollars. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in 7-12 deals per year. The higher amount of exits for fund were in 2019.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the SBI Group, startups are often financed by SBI Ven Capital, East Ventures, Route 66 Ventures. The meaningful sponsors for the fund in investment in the same round are Magma Venture Partners, Vertex Ventures Israel, Vertex Ventures. In the next rounds fund is usually obtained by AddVentures by SCG, Vertex Ventures Israel, Vertex Ventures.

Among the various public portfolio startups of the fund, we may underline, Ping An Healthcare Management, Rakuten Medical Among the most popular fund investment industries, there are Bitcoin, Financial Services. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SBI Group:
Typical Co-investors
SBI Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SBI Group:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Digital Asset

Developer Platform
Developer Tools
Financial Services
Risk Management
27 May 2022 New York, New York, United States


$108M29 Mar 2022 Chiyoda, Japan

Modulus Discovery

Clinical Trials
$20M01 Mar 2022 Chiyoda, Japan


Consumer Electronics
$3M24 Feb 2022 Zürich, Zurich, Switzerland


$10M16 Feb 2022 Cianjur, West Java, Indonesia

Lancium Technologies

Information Technology
Renewable Energy
$150M23 Nov 2021 Houston, Texas, United States


$60M11 Oct 2021 London, England, United Kingdom


Financial Services
Stock Exchanges
$19M31 Aug 2021 Chiyoda, Japan

Rakuten Medical

$166M28 Jul 2021 California, United States
Rakuten Medical Closes $166M in Series D Funding

– Rakuten Medical from San Mateo is developing and commercializing innovative oncology products for multiple indications.
– The company raised $166m in Series D funding.
– The round was led by General Catalyst with additional participation from existing investors, including Rakuten Group and SBI Group.
– The new investment will be used to advance ongoing trials of ASP-1929 in several oncologic indications and research and development of additional pipeline therapies being developed using the Illuminox™ platform.

Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure

– Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), announced it has raised 4 Billion-yen (approx. $37 Million) at Series C round, bringing its total financial backing to 8.2 Billion yen (approx. $75 Million) since its foundation in 2015.
– New investors are UTokyo Innovation Platform Co. (UTokyo IPC), Medical Incubator Japan, Keio Innovation Initiative (KII), and Sumitomo Mitsui Trust Investment. Among the existing investors, SBI Group, Nissay Capital, SMBC Capital, Medipal Holdings, and Itochu Chemical Frontier participated in this round.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SBI Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: